-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tyra Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Tyra Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$23.5M, a 46.9% decline year-over-year.
- Tyra Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$95.5M, a 61.7% decline year-over-year.
- Tyra Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$79.9M, a 35.7% decline from 2022.
- Tyra Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$58.9M, a 124% decline from 2021.
- Tyra Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$26.3M, a 183% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)